DK173589D0 - Antibiotisk polypeptid benaevnt kedarcidin og fremgangsmaade til fremstilling deraf - Google Patents

Antibiotisk polypeptid benaevnt kedarcidin og fremgangsmaade til fremstilling deraf

Info

Publication number
DK173589D0
DK173589D0 DK173589A DK173589A DK173589D0 DK 173589 D0 DK173589 D0 DK 173589D0 DK 173589 A DK173589 A DK 173589A DK 173589 A DK173589 A DK 173589A DK 173589 D0 DK173589 D0 DK 173589D0
Authority
DK
Denmark
Prior art keywords
kedarcidin
producing
polypeptide used
antibiotic
antibiotic polypeptide
Prior art date
Application number
DK173589A
Other languages
English (en)
Other versions
DK173589A (da
DK174751B1 (da
Inventor
Sandra J Hofstead
James Andrew Matson
Kin Sing Lam
Salvatore Forenza
James A Bush
Koji Tomita
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of DK173589D0 publication Critical patent/DK173589D0/da
Publication of DK173589A publication Critical patent/DK173589A/da
Application granted granted Critical
Publication of DK174751B1 publication Critical patent/DK174751B1/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/36—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Actinomyces; from Streptomyces (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pyrane Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
DK198901735A 1988-04-12 1989-04-11 Antibiotisk kedarcidin, fremgangsmåde til fremstilling deraf, farmaceutisk præparat indeholdende kedarcidin samt den kedarcidin-producerende mikroorganisme Streptoalloteichus sp. nov. stamme L585-6, ATCC 53650 DK174751B1 (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US18051988A 1988-04-12 1988-04-12
US18051988 1988-04-12
US07/323,001 US5001112A (en) 1988-04-12 1989-03-17 Antitumor antibiotic kedarcidin
US32300189 1989-03-17

Publications (3)

Publication Number Publication Date
DK173589D0 true DK173589D0 (da) 1989-04-11
DK173589A DK173589A (da) 1989-10-13
DK174751B1 DK174751B1 (da) 2003-10-20

Family

ID=26876396

Family Applications (1)

Application Number Title Priority Date Filing Date
DK198901735A DK174751B1 (da) 1988-04-12 1989-04-11 Antibiotisk kedarcidin, fremgangsmåde til fremstilling deraf, farmaceutisk præparat indeholdende kedarcidin samt den kedarcidin-producerende mikroorganisme Streptoalloteichus sp. nov. stamme L585-6, ATCC 53650

Country Status (24)

Country Link
US (1) US5001112A (da)
EP (1) EP0337430B1 (da)
JP (1) JP2850132B2 (da)
KR (1) KR970010137B1 (da)
CN (1) CN1034589C (da)
AT (1) ATE101653T1 (da)
AU (1) AU623641B2 (da)
CA (1) CA1338262C (da)
CY (1) CY1849A (da)
DE (1) DE68913063T2 (da)
DK (1) DK174751B1 (da)
ES (1) ES2061760T3 (da)
FI (1) FI93969C (da)
HK (1) HK83195A (da)
HU (1) HU201119B (da)
IE (1) IE62912B1 (da)
IL (1) IL89896A0 (da)
MY (1) MY105842A (da)
NO (1) NO174474C (da)
NZ (1) NZ228672A (da)
PL (1) PL161004B1 (da)
PT (1) PT90252B (da)
SG (1) SG30654G (da)
YU (1) YU73989A (da)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5143906A (en) * 1991-09-26 1992-09-01 Bristol-Myers Squibb Company Kedarcidin antitumor chromophore and pharmaceutical composition containing same
WO2003062458A2 (en) * 2002-01-24 2003-07-31 Ecopia Biosciences Inc. Method, system and knowledge repository for identifying a secondary metabolite from a microorganism
AU2009309416B2 (en) * 2008-10-27 2015-05-28 Glaxosmithkline Biologicals S.A. Purification method

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS519837B2 (da) * 1974-03-29 1976-03-30
JPS53107408A (en) * 1977-02-28 1978-09-19 Yamanouchi Pharmaceut Co Ltd Micellar preparation for rectal infusion
JPS6017206B2 (ja) * 1977-03-24 1985-05-01 浩 前田 ネオカルチノスタチン誘導体の製造法
JPS56113791A (en) * 1980-02-15 1981-09-07 Kaken Pharmaceut Co Ltd Novel antibiotic and its preparation
JPS57206693A (en) * 1981-06-10 1982-12-18 Ajinomoto Co Inc Protein an-7d
JPS59184135A (ja) * 1983-04-04 1984-10-19 Teijin Ltd グリセリンピログルタミン酸エステル類を含有する医薬品組成物

Also Published As

Publication number Publication date
SG30654G (en) 1995-09-01
ATE101653T1 (de) 1994-03-15
NO174474B (no) 1994-01-31
CA1338262C (en) 1996-04-23
PL161004B1 (pl) 1993-05-31
DE68913063D1 (de) 1994-03-24
FI93969B (fi) 1995-03-15
CN1037735A (zh) 1989-12-06
PT90252A (pt) 1989-11-10
DK173589A (da) 1989-10-13
PT90252B (pt) 1994-07-29
NZ228672A (en) 1990-07-26
DK174751B1 (da) 2003-10-20
EP0337430B1 (en) 1994-02-16
CY1849A (en) 1996-03-08
NO891462L (no) 1989-10-13
EP0337430A3 (en) 1991-07-24
HU201119B (en) 1990-09-28
FI93969C (fi) 1995-06-26
KR970010137B1 (ko) 1997-06-21
CN1034589C (zh) 1997-04-16
JP2850132B2 (ja) 1999-01-27
KR900016469A (ko) 1990-11-13
IE62912B1 (en) 1995-03-08
YU73989A (en) 1991-04-30
DE68913063T2 (de) 1994-06-09
NO174474C (no) 1998-06-09
HK83195A (en) 1995-06-01
PL278782A1 (en) 1989-12-27
ES2061760T3 (es) 1994-12-16
HUT50880A (en) 1990-03-28
AU623641B2 (en) 1992-05-21
IL89896A0 (en) 1989-12-15
IE891157L (en) 1989-10-12
AU3272889A (en) 1989-10-19
FI891710A0 (fi) 1989-04-11
NO891462D0 (no) 1989-04-10
JPH01317396A (ja) 1989-12-22
EP0337430A2 (en) 1989-10-18
MY105842A (en) 1995-01-30
US5001112A (en) 1991-03-19
FI891710A (fi) 1989-10-13

Similar Documents

Publication Publication Date Title
EP0714665A3 (en) Osteogenic devices
EP0575555A4 (en) PROTEIN-INDUCING MORPHOGENESIS.
AU1422492A (en) Pea protein hydrolyzate, method for production thereof and use thereof
EP0489711A3 (en) Method for producing human growth hormone
ES2087323T3 (es) Metodo para producir peptidos exentos de cisteina.
ATE107362T1 (de) Polypeptid-mutanten des menschlichen tnf und für diese mutanten codierende dns.
AU5245186A (en) Oxidation resistant mutant proteins
DK429585D0 (da) Antibakterielt virksomme 4,5-dihydro-4-oxo-2-((2-trans-phenylcyclopropyl)amino)-3-furancarboxylsyrer og derivater deraf
DK173589A (da) Antibiotisk polypeptid benaevnt kedarcidin og fremgangsmaade til fremstilling deraf
EP0490383A3 (en) Peptides of the hiv-gag protein, their preparation and use

Legal Events

Date Code Title Description
B1 Patent granted (law 1993)
PBP Patent lapsed

Country of ref document: DK